willis towers watson plc - WTW
WTW
Close Chg Chg %
329.45 -2.03 -0.62%
Closed Market
327.42
-2.03 (0.62%)
Volume: 535.12K
Last Updated:
Jan 13, 2026, 4:00 PM EDT
Company Overview: willis towers watson plc - WTW
WTW Key Data
| Open $329.84 | Day Range 323.03 - 329.84 |
| 52 Week Range 292.97 - 352.79 | Market Cap $31.54B |
| Shares Outstanding 95.75M | Public Float 95.43M |
| Beta 0.64 | Rev. Per Employee N/A |
| P/E Ratio 15.76 | EPS $21.13 |
| Yield 111.43% | Dividend $0.92 |
| EX-DIVIDEND DATE Dec 31, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 519.34K |
WTW Performance
| 1 Week | -0.25% | ||
| 1 Month | 0.77% | ||
| 3 Months | -2.24% | ||
| 1 Year | 5.28% | ||
| 5 Years | 59.42% |
WTW Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
26
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 369.70 | |
| Number of Ratings | 26 | Current Quarters Estimate | 3.617 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 19.319 | |
| Last Quarter’s Earnings | 7.994 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 16.966 | Next Fiscal Year Estimate | 22.06 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 19 | 19 | 22 | 19 |
| Mean Estimate | 3.62 | 3.19 | 19.32 | 22.06 |
| High Estimates | 3.82 | 3.49 | 20.11 | 23.21 |
| Low Estimate | 3.45 | 2.90 | 17.82 | 19.96 |
| Coefficient of Variance | 2.96 | 3.60 | 2.51 | 4.00 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 13 | 13 | 12 |
| OVERWEIGHT | 3 | 3 | 3 |
| HOLD | 9 | 8 | 9 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 1 | 1 | 1 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Willis Towers Watson Plc - WTW
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Willis Towers Watson Plc - WTW
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jul 16, 2025 | Andrew Krasner Chief Financial Officer | 669 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 16, 2025 | Carl Aaron Hess Chief Executive Officer; Director | 9,409 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 16, 2025 | Carl Aaron Hess Chief Executive Officer; Director | 8,040 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 16, 2025 | Andrew Krasner Chief Financial Officer | 1,946 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 16, 2025 | Julie Jarecke Gebauer Pres.-Health, Wealth & Career | 5,341 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 16, 2025 | Anne Pullum Head of Europe | 2,325 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 16, 2025 | Imran Ahmed Qureshi Head of North America | 2,839 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Paul C. Reilly Director | 1,291 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $303.37 per share | 391,650.67 |
| May 20, 2025 | Fumbi Chima Director | 2,319 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $303.37 per share | 703,515.03 |
| May 20, 2025 | Inga Kristine Beale Director | 2,264 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Inga Kristine Beale Director | 1,554 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $303.37 per share | 471,436.98 |
| May 20, 2025 | Jacqueline Hunt Director | 1,688 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Jacqueline Hunt Director | 978 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $303.37 per share | 296,695.86 |
| May 20, 2025 | Stephen Mark Chipman Director | 1,688 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Stephen Mark Chipman Director | 978 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $303.37 per share | 296,695.86 |
| May 20, 2025 | Paul C. Reilly Director | 2,323 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Paul Donald Thomas Director | 13,043 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $303.37 per share | 3,956,854.91 |
| May 20, 2025 | Michael Hammond Director | 2,264 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Fumbi Chima Director | 3,432 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Fredric John Tomczyk Director | 1,688 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |